NIAID Banner Logo Image

HBV Drugs in Development

Drug ClassSponsor and/or CompanyDrug NameAlt NameDrug StatusNotesAIDS#
Antibody, MonoclonalGreen Cross CorporationGC1102Recombinant Hepatitis B ImmunoglobulinPhase 2Completed 
Antibody, MonoclonalVir BiotechnologyVIR-3434 Phase 2Recruiting 
Antibody, Monoclonal (PDL1 Inhibitor)Ascletis PharmaceuticalsEnvafolimabASC22; KN035Phase 2Recruiting 
Apoptosis InducerAscentage Pharma GroupAPG-1387 Phase 2Recruiting 
Core Protein / Capsid InhibitorJanssen SciencesJNJ 56136379JNJ-6379Phase 2Completed 
Core Protein / Capsid InhibitorEnanta PharmaceuticalsEDP-514 Phase 1Completed 
Core Protein / Capsid InhibitorAligos TherapeuticsALG-000184 Phase 1Recruiting 
Core Protein / Capsid InhibitorAssembly BiosciencesABI-H3733 Phase 1Completed 
Core Protein / Capsid InhibitorAssembly BiosciencesABI-H2158 Phase 2Terminated 
Core Protein / Capsid InhibitorQilu PharmaceuticalsQL-007 Phase 2Unknown 
Core Protein / Capsid InhibitorAssembly BiosciencesVebicorvirABI-H0731Phase 2Active, Not Recruiting 
FXR AgonistEnyo PharmaEYP001a Phase 2Terminated 
RNA Gene Silencer (Antisense Oligonucleotide)Ionis Pharmaceuticals and GlaxoSmithKlineIONIS-HBVRxGSK3228836Phase 2Completed 
RNA Gene Silencer (RNAi / siRNA)Janssen Research & DevelopmentJNJ-73763989JNJ-3989Phase 2Completed 
RNA Gene Silencer (RNAi / siRNA)Dicerna PharmaceuticalsDCR HBVS Phase 1Completed 
RNA Gene Silencer (RNAi / siRNA)Vir BiotechnologyVIR-2218 Phase 2Completed 
TLR-8 AgonistGilead SciencesSelgantolimodGS9688Phase 2Completed 
Viral Polymerase InhibitorAntios TherapeuticsATI-2173Prodrug of ClevudinePhase 2Terminated 
Viral Polymerase InhibitorGlaxoSmithKlineTenofovir Disoproxil FumarateGSK548470Phase 3Completed 080741
Viral Polymerase InhibitorDong-A ST Co.Tenofovir Disoproxil OrotateDA-2802Phase 3Completed 

Sources: and sponsor websites.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: April 2023